X

pharmaceuticals

Is Merck & Co. (MRK) a good investment after Q1 earnings?

Merck & Co., Inc. (NYSE: MRK) is recovering from the virus-induced slowdown supported by stable demand across its product line…

Trxade Health (MEDS) reports 6% growth in Q1 revenue; loss widens

Pharmaceutical services company Trxade Health Inc (NASDAQ: MEDS) Monday reported a wider net loss for the first quarter of 2022 despite…

Infographic: Highlights of Merck’s (MRK) Q1 2022 earnings

Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than-expected earnings and revenues for the first quarter of 2022. The…

Biogen’s (BIIB) long-term prospects look intact despite Alzheimer’s drug setback

Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition…

Stock Watch: Should you invest in Eli Lilly (LLY) after Q1 earnings?

For Eli Lilly and Company (NYSE: LLY), 2021 was a fruitful year in terms of financial performance and product development.…

Pfizer (PFE) anticipates an increase in orders for Paxlovid in coming months due to virus mutations

Shares of Pfizer Inc. (NYSE: PFE) gained nearly 2% on Tuesday after the company delivered better-than-expected results for the first…

Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It…

PFE Earnings: All you need to know about Pfizer’s Q1 2022 earnings results

Pfizer Inc. (NYSE: PFE) reported first quarter 2022 earnings results today. Total revenues increased 77% year-over-year to $25.7 billion. Reported…

Earnings: Highlights of Eli Lilly’s (LLY) Q1 2022 results

Eli Lilly and Company (NYSE: LLY) has reported higher earnings and revenues for the first quarter of 2022. The numbers…

Infographic: Highlights of Intuitive Surgical’s Q1 2022 earnings

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in…

Abbott Laboratories (ABT) Q1 2022 Infographic: Key financials and quarterly highlights

Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for…

Johnson & Johnson (JNJ) reports Q1 2022 earnings

Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday. The pharmaceutical giant…

AngioDynamics (ANGO) Q3 earnings beat estimates as sales increase

AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker's…

Infographic: Highlights of Cronos’ (CRON) Q4 2021 earnings report

Cronos Group Inc. (NASDAQ: CRON) has reported a wider net loss for the fourth quarter of 2021, despite a double-digit…

Infographic: How Tilray (TLRY) performed in Q3 2022

Tilray (NASDAQ: TLRY) reported third-quarter 2022 financial results before the regular market hours on Wednesday. Total net revenue increased 23%…

Trxade will stay focused on traditional technology platform for margin growth: CEO Suren Ajjarapu

Can you briefly talk about your business model and the value you add to the market? Trxade (NASDAQ: MEDS) is…

Why Intuitive Surgical (ISRG) is a must-own stock after the recent dip

The pandemic had a mixed impact on the healthcare sector. The high demand for COIVD care services sent medical facilities…

HEXO Earnings: Highlights of Hexo’s Q2 2022 financial results

Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a wider net loss for the second quarter of 2022. However, the…

Cipher Pharmaceuticals Inc. (CPH) Q4 2021 Earnings Call Transcript

Cipher Pharmaceuticals, Inc. ( TSX: CPH) Q4 2021 earnings call dated Mar. 18, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive…

Should you invest in Walgreens Boots Alliance ahead of earnings?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been busy enhancing its capabilities in healthcare delivery lately, through various initiatives including…

ANI Pharmaceuticals, Inc. (ANIP) Q4 2021 Earnings Call Transcript

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q4 2021 earnings call dated Mar. 15, 2022 Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President…